Diadema Partners LP Replimune Group, Inc. Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
A detailed history of Diadema Partners LP transactions in Replimune Group, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 74,530 shares of REPL stock, worth $732,629. This represents 0.19% of its overall portfolio holdings.
Number of Shares
74,530
Previous 114,000
34.62%
Holding current value
$732,629
Previous $1.38 Billion
47.36%
% of portfolio
0.19%
Previous 0.59%
Shares
2 transactions
Others Institutions Holding REPL
# of Institutions
172Shares Held
78.5MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$109 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$107 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$48.2 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$46.3 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$38.4 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $485M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...